Philip Tsai serves as Executive at Immunome Inc., where they oversee executive responsibilities. Since joining the company, Philip Tsai has executed 1 insider transactions totaling $204.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 19, 2025 involved purchasing 10,000 shares valued at $204.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | IMNM | $204.9K | Purchase | 10,000 | $20.49 | Discretionary |
Philip Tsai currently holds 43,300 shares of Immunome Inc. (IMNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip Tsai has been a net buyer of IMNM stock. They have purchased $204.9K and sold $0 worth of shares.
Philip Tsai's most recent insider trade was on Dec 19, 2025, when they purchased 10,000 shares at $20.49 per share.
Get notified when new Form 4 filings are submitted